Personalis, Inc. Increase (Decrease) in Accounts Receivable
Personalis, Inc. (PSNL) reported Increase (Decrease) in Accounts Receivable of -$1.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-04
- Personalis, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $2.08M.
- Personalis, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$3.18M, a 212.28% decline year-over-year.
- Personalis, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $1.83M.
- Personalis, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $4.42M, a 698.56% increase year-over-year.
- Personalis, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $8.06M.
- Personalis, Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$9.59M, a 981.43% decline from fiscal 2023.
- Personalis, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $1.09M.
- Personalis, Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$1.82M, a 115.06% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$1.10M 10-Q · filed 2026-08-04 | $726.00K derived: sum of 3 quarters · filed 2026-08-04 | $5.15M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$3.18M 10-Q · filed 2026-05-07 | -$1.35M derived: sum of 2 quarters · filed 2026-05-07 | $3.07M derived: sum of 3 quarters · filed 2026-05-07 | $2.05M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.25M derived: sum of 2 quarters · filed 2026-02-26 | $5.23M derived: sum of 3 quarters · filed 2026-08-04 | $8.06M 10-K · filed 2026-02-26 |
| 2025-09-30 | $4.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.40M derived: sum of 2 quarters · filed 2026-08-04 | $6.24M 10-Q · filed 2025-11-04 | $901.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.81M 10-Q · filed 2026-08-04 | -$3.52M derived: sum of 3 quarters · filed 2026-08-04 | -$2.97M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $2.83M 10-Q · filed 2026-05-07 | -$2.50M derived: sum of 2 quarters · filed 2026-05-07 | -$1.95M derived: sum of 3 quarters · filed 2026-05-07 | -$372.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$5.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.78M derived: sum of 2 quarters · filed 2026-02-26 | -$3.21M derived: sum of 3 quarters · filed 2026-02-26 | -$9.59M 10-K · filed 2026-02-26 |
| 2024-09-30 | $554.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.13M derived: sum of 2 quarters · filed 2025-11-04 | -$4.25M 10-Q · filed 2025-11-04 | -$191.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$4.81M 10-Q · filed 2025-08-05 | -$745.00K derived: sum of 3 quarters · filed 2025-08-05 | $2.79M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$6.38M 10-Q · filed 2025-05-06 | -$2.32M derived: sum of 2 quarters · filed 2025-05-06 | $1.21M derived: sum of 3 quarters · filed 2025-05-06 | -$6.76M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $7.60M derived: sum of 2 quarters · filed 2025-02-27 | -$372.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.09M 10-K · filed 2025-02-27 |
| 2023-09-30 | $3.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$4.44M derived: sum of 2 quarters · filed 2024-11-06 | -$2.98M 10-Q · filed 2024-11-06 | $75.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$7.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$6.51M 10-Q · filed 2024-08-07 | -$3.46M derived: sum of 3 quarters · filed 2024-08-07 | -$2.74M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $1.46M 10-Q · filed 2024-05-08 | $4.51M derived: sum of 2 quarters · filed 2024-05-08 | $5.23M derived: sum of 3 quarters · filed 2024-05-08 | $4.58M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.77M derived: sum of 2 quarters · filed 2024-02-28 | $3.12M derived: sum of 3 quarters · filed 2024-02-28 | -$1.82M 10-K · filed 2024-02-28 |
| 2022-09-30 | $715.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $73.00K derived: sum of 2 quarters · filed 2023-11-07 | -$4.88M 10-Q · filed 2023-11-07 | $3.06M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$642.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$5.59M 10-Q · filed 2023-08-08 | $2.34M derived: sum of 3 quarters · filed 2024-02-28 | $3.60M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$4.95M 10-Q · filed 2023-05-03 | $2.98M derived: sum of 2 quarters · filed 2024-02-28 | $4.24M derived: sum of 3 quarters · filed 2024-02-28 | $5.47M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $7.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $9.19M derived: sum of 2 quarters · filed 2024-02-28 | $10.41M derived: sum of 3 quarters · filed 2024-02-28 | $12.12M 10-K · filed 2024-02-28 |
| 2021-09-30 | $1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $2.48M derived: sum of 2 quarters · filed 2022-11-02 | $4.18M 10-Q · filed 2022-11-02 | $4.63M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $2.93M 10-Q · filed 2022-08-03 | $3.37M derived: sum of 3 quarters · filed 2023-02-23 | $3.90M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $1.70M 10-Q · filed 2022-05-04 | $2.15M derived: sum of 2 quarters · filed 2023-02-23 | $2.68M derived: sum of 3 quarters · filed 2023-02-23 | $2.54M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $974.00K derived: sum of 2 quarters · filed 2023-02-23 | $841.00K derived: sum of 3 quarters · filed 2023-02-23 | $3.05M 10-K · filed 2023-02-23 |
| 2020-09-30 | $528.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $395.00K derived: sum of 2 quarters · filed 2021-11-04 | $2.60M 10-Q · filed 2021-11-04 | $1.46M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $2.08M 10-Q · filed 2021-08-04 | $931.00K derived: sum of 3 quarters · filed 2022-02-24 | -$2.00M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $2.21M 10-Q · filed 2021-05-05 | $1.06M derived: sum of 2 quarters · filed 2022-02-24 | -$1.87M derived: sum of 3 quarters · filed 2022-02-24 | $2.48M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$4.08M derived: sum of 2 quarters · filed 2022-02-24 | $277.00K derived: sum of 3 quarters · filed 2022-02-24 | -$1.07M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.42M derived: sum of 2 quarters · filed 2020-11-05 | $75.00K 10-Q · filed 2020-11-05 | $1.43M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $4.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.01M 10-Q · filed 2020-08-06 | $4.37M derived: sum of 3 quarters · filed 2021-02-25 | $3.29M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$1.35M 10-Q · filed 2020-05-07 | $13.00K derived: sum of 2 quarters · filed 2021-02-25 | -$1.07M derived: sum of 3 quarters · filed 2021-02-25 | |
| 2018-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $279.00K derived: sum of 2 quarters · filed 2021-02-25 | $2.52M 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $1.16M 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $2.24M 10-Q · filed 2019-08-13 | |||
| 2017-12-31 | $1.20M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |